Öfverholm, I.; Lin, Y.; Mondini, J.; Hardingz, J.; Bränström, R.; Tsagkozis, P.; Wirta, V.; Gellerbring, A.; Lindberg, J.; Chellappa, V.;
et al. Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors. Cancers 2024, 16, 3816.
https://doi.org/10.3390/cancers16223816
AMA Style
Öfverholm I, Lin Y, Mondini J, Hardingz J, Bränström R, Tsagkozis P, Wirta V, Gellerbring A, Lindberg J, Chellappa V,
et al. Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors. Cancers. 2024; 16(22):3816.
https://doi.org/10.3390/cancers16223816
Chicago/Turabian Style
Öfverholm, Ingegerd, Yingbo Lin, Julia Mondini, John Hardingz, Robert Bränström, Panagiotis Tsagkozis, Valtteri Wirta, Anna Gellerbring, Johan Lindberg, Venkatesh Chellappa,
and et al. 2024. "Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors" Cancers 16, no. 22: 3816.
https://doi.org/10.3390/cancers16223816
APA Style
Öfverholm, I., Lin, Y., Mondini, J., Hardingz, J., Bränström, R., Tsagkozis, P., Wirta, V., Gellerbring, A., Lindberg, J., Chellappa, V., Mayrhofer, M., Haglund, C., Haglund de Flon, F., & Wallander, K.
(2024). Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors. Cancers, 16(22), 3816.
https://doi.org/10.3390/cancers16223816
